ArticleJournal of community genetics2026
Rare diseases, body, and stigma: a comparative analysis of people living with berardinelli syndrome and Machado-Joseph disease in Brazil.
Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesThis article analyses how people living with rare diseases are stigmatised due to physical features and bodily alterations, considering the moral dimensions through which these differences are read. The analysis draws on research conducted in two regions of Brazil (Northeast and Southeast) with people affected by two hereditary rare conditions: Berardinelli Syndrome (BS) and Machado-Joseph Disease (MJD). We selected these conditions because of their significant bodily transformations: BS is present from birth, whereas MJD emerges in adulthood. This enabled us to examine how stigma is managed within families across the life course and identify who, beyond those directly affected, experiences its impacts.
methodsThe article draws on data from two research projects conducted at different times. Both involved ethnographic fieldwork in hospitals and public events organised by patient associations, as well as in-depth interviews with patients and family members. Materials were analysed through narrative analysis. RESULTS AND DISCUSSION: Our analysis was guided by three lines of inquiry concerning the construction and perception of stigma among people living with BS and MJD: (1) recognition of the first symptoms and lay interpretations of illness, leading to encounters with genetic explanations for its causation; (2) experiences of stigma through the interplay between bodily changes and gender expectations in the context of rare disease; and (3) health activism as a mechanism for coping with stigma.
findingsOur findings reveal how the intersection of body, stigma, and identity produces moral readings of people living with rare diseases, based on the social interpretation of bodily changes brought about by these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.